LTA Antibody (Center) Blocking Peptide

Catalog Number: ABT-BP8509C
Article Name: LTA Antibody (Center) Blocking Peptide
Biozol Catalog Number: ABT-BP8509C
Supplier Catalog Number: BP8509c
Alternative Catalog Number: ABT-BP8509C-500UG
Manufacturer: Abcepta
Category: Proteine/Peptide
Alternative Names: Lymphotoxin-alpha, LT-alpha, TNF-beta, Tumor necrosis factor ligand superfamily member 1, LTA, TNFB, TNFSF1
LTA, a member of the tumor necrosis factor family, is a cytokine produced by lymphocytes. The protein is highly inducible, secreted, and forms heterotrimers with lymphotoxin-beta which anchor lymphotoxin-alpha to the cell surface. This protein also mediates a large variety of inflammatory, immunostimulatory, and antiviral responses, is involved in the formation of secondary lymphoid organs during development and plays a role in apoptosis.
NCBI: 4049
UniProt: P01374
Form: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Target: The synthetic peptide sequence used to generate the antibody AP8509c was selected from the Center region of human LTA. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.